TW360548B
(en)
|
1993-04-08 |
1999-06-11 |
Powderject Res Ltd |
Products for therapeutic use
|
CN1112943C
(zh)
*
|
1994-01-21 |
2003-07-02 |
粉剂注射疫苗股份有限公司 |
气体驱动的基因送递装置
|
US5899880A
(en)
*
|
1994-04-08 |
1999-05-04 |
Powderject Research Limited |
Needleless syringe using supersonic gas flow for particle delivery
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
MX9701394A
(es)
*
|
1994-08-04 |
1998-03-31 |
Quadrant Holdings Cambridge |
Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos.
|
GB9416663D0
(en)
*
|
1994-08-17 |
1994-10-12 |
Oxford Bioscience Limited |
Particle delivery
|
GB9426379D0
(en)
|
1994-12-23 |
1995-03-01 |
Oxford Biosciences Ltd |
Particle delivery
|
GB9502879D0
(en)
*
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
US5766901A
(en)
*
|
1995-05-04 |
1998-06-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and method for delivering a nucleotide into cell nuclei
|
US6474369B2
(en)
|
1995-05-26 |
2002-11-05 |
Penjet Corporation |
Apparatus and method for delivering a lyophilized active with a needle-less injector
|
US7223739B1
(en)
|
1995-06-07 |
2007-05-29 |
Powderject Vaccines, Inc. |
Adjuvanted genetic vaccines
|
DE69628095T2
(de)
*
|
1995-08-02 |
2004-02-19 |
The Boc Group Plc, Windlesham |
Gaszuführvorrichtung
|
GB9515846D0
(en)
*
|
1995-08-02 |
1995-10-04 |
Boc Group Plc |
Gas capsule
|
US6080130A
(en)
*
|
1998-11-14 |
2000-06-27 |
Castellano; Thomas P. |
Gas power source for a needle-less injector
|
US6013050A
(en)
*
|
1995-10-20 |
2000-01-11 |
Powderject Research Limited |
Particle delivery
|
GB9605690D0
(en)
*
|
1996-03-19 |
1996-05-22 |
Oxford Biosciences Ltd |
Particle delivery
|
WO1997047730A1
(fr)
*
|
1996-06-14 |
1997-12-18 |
Powderject Vaccines, Inc. |
Module de conduite d'echantillons pour un appareil d'acceleration de particules
|
US6893664B1
(en)
*
|
1996-06-17 |
2005-05-17 |
Powderject Research Limited |
Particle delivery techniques
|
EP0921827B1
(fr)
|
1996-07-01 |
2003-10-22 |
Pharmacia Aktiebolag |
Dispositif d'administration et procede de fonctionnement dudit dispositif
|
CA2209406C
(fr)
|
1996-07-24 |
2007-05-15 |
David W. Birch |
Capsule de gaz et systdme de distribution de gaz
|
US6468782B1
(en)
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
DE19701494A1
(de)
|
1997-01-17 |
1998-07-23 |
Boehringer Mannheim Gmbh |
Transdermales Injektionssystem
|
US5947928A
(en)
*
|
1997-06-19 |
1999-09-07 |
Mile Creek Capital, Llc |
Drug delivery system
|
EP0888791A1
(fr)
*
|
1997-07-04 |
1999-01-07 |
PowderJect Research Limited |
Seringue et capsule de medicament correspondante
|
EP0888790A1
(fr)
*
|
1997-07-04 |
1999-01-07 |
PowderJect Research Limited |
Appareil d'apport de particules medicamenteuses
|
US6074360A
(en)
|
1997-07-21 |
2000-06-13 |
Boehringer Mannheim Gmbh |
Electromagnetic transdermal injection device and methods related thereto
|
US6171276B1
(en)
|
1997-08-06 |
2001-01-09 |
Pharmacia & Upjohn Ab |
Automated delivery device and method for its operation
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
DE19820172A1
(de)
*
|
1997-09-30 |
2005-01-27 |
Wolfgang Wagner |
Einrichtung und einrichtungsbezogenes Verfahren zur Einbringung eines Diagnostikträgers oder einer Arznei unter die Haut eines Lebewesens
|
EP1032429B1
(fr)
*
|
1997-11-20 |
2003-05-28 |
Aventis Pasteur |
Procede servant a administrer de l'adn in vivo au moyen d'un dispositif sans aiguille
|
WO1999027961A1
(fr)
*
|
1997-12-02 |
1999-06-10 |
Powderject Vaccines, Inc. |
Administration transdermique de compositions particulaires de vaccins
|
JP2003528024A
(ja)
*
|
1997-12-16 |
2003-09-24 |
バレンティス・インコーポレーテッド |
製剤化された核酸分子の無針注入
|
GB9802508D0
(en)
*
|
1998-02-05 |
1998-04-01 |
Boc Group Plc |
Needleless medical device
|
GB9802506D0
(en)
*
|
1998-02-05 |
1998-04-01 |
Boc Group Plc |
Needleless medical device
|
US6686339B1
(en)
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
US6693087B1
(en)
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
EP1105490A1
(fr)
|
1998-08-20 |
2001-06-13 |
Aventis Pasteur Limited |
Molecules d'acide nucleique codant la proteine membrane d'inclusion c de chlamydia
|
GB9818627D0
(en)
*
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
GB9819272D0
(en)
*
|
1998-09-03 |
1998-10-28 |
Andaris Ltd |
Microparticles
|
US6558961B1
(en)
*
|
1998-09-04 |
2003-05-06 |
Powderject Research Limited |
Immunodiagnostics using particle delivery methods
|
WO2000013573A1
(fr)
|
1998-09-04 |
2000-03-16 |
Powderject Research Limited |
Methodes de controle reposant sur des techniques d'apport de particules
|
US6602678B2
(en)
|
1998-09-04 |
2003-08-05 |
Powderject Research Limited |
Non- or minimally invasive monitoring methods
|
USD434848S
(en)
*
|
1998-09-08 |
2000-12-05 |
Powderject Research Limited |
Disposable injector
|
AU765957B2
(en)
|
1998-10-01 |
2003-10-02 |
Powderject Research Limited |
Spray coated microparticles for use in needleless syringes
|
DE69930294T2
(de)
*
|
1998-10-19 |
2006-11-02 |
Powderject Vaccines, Inc., Madison |
Minimale promotoren und ihre verwendung
|
FR2785293B1
(fr)
|
1998-10-30 |
2002-07-05 |
Pasteur Merieux Serums Vacc |
Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
GB9825763D0
(en)
*
|
1998-11-25 |
1999-01-20 |
Boc Group Plc |
Filling containers with gas
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
IL144380A0
(en)
*
|
1999-01-22 |
2002-05-23 |
Powderject Res Ltd |
Method of enhancing needleless transdermal powdered drug delivery
|
US6849060B1
(en)
*
|
1999-01-29 |
2005-02-01 |
Powderject Research Limited |
Particle delivery device
|
US6328714B1
(en)
|
1999-01-29 |
2001-12-11 |
Powderject Research Limited |
Particle delivery device
|
WO2000045792A1
(fr)
*
|
1999-02-03 |
2000-08-10 |
Powderject Research Limited |
Preparations de particules hydrogel
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
CA2364198A1
(fr)
*
|
1999-03-08 |
2000-09-14 |
Powderject Research Limited |
Administration de formulations microparticulaires a l'aide d'une seringue sans aiguille pour la liberation lente de composes bioactifs
|
US20050214227A1
(en)
*
|
1999-03-08 |
2005-09-29 |
Powderject Research Limited |
Microparticle formulations for sustained-release of bioactive compounds
|
GB9905933D0
(en)
*
|
1999-03-15 |
1999-05-05 |
Powderject Res Ltd |
Neeedleless syringe
|
US7013617B2
(en)
|
1999-04-01 |
2006-03-21 |
The Boc Group, Plc |
Method of filling and sealing
|
MXPA01010470A
(es)
*
|
1999-04-16 |
2004-04-05 |
Powderject Res Ltd |
Jeringa sin agua.
|
WO2000062759A1
(fr)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Formulation pharmaceutique seche et moulable
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
FR2796290B1
(fr)
|
1999-07-16 |
2001-09-14 |
Cross Site Technologies |
Seringue sans aiguille fonctionnant avec un generateur d'onde de choc a travers une paroi
|
GB9916800D0
(en)
*
|
1999-07-16 |
1999-09-22 |
Powderject Res Ltd |
Needleless syringe
|
FR2796288B1
(fr)
*
|
1999-07-16 |
2001-08-10 |
Cross Site Technologies |
Seringue sans aiguille avec injecteur a elements emboites
|
US20050027239A1
(en)
*
|
1999-08-20 |
2005-02-03 |
Stout Richard R. |
Intradermal injection system for injecting DNA-based injectables into humans
|
US6319224B1
(en)
*
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
US6811783B1
(en)
|
1999-09-07 |
2004-11-02 |
Aventis Pasteur Limited |
Immunogenic compositions for protection against chlamydial infection
|
DE19946059A1
(de)
*
|
1999-09-25 |
2001-03-29 |
Roche Diagnostics Gmbh |
System zur transdermalen Gewinnung von Körperflüssigkeit
|
GB9923306D0
(en)
|
1999-10-01 |
1999-12-08 |
Isis Innovation |
Diagnostic and therapeutic epitope, and transgenic plant
|
WO2001026717A1
(fr)
|
1999-10-11 |
2001-04-19 |
Needleless Ventures, Inc. |
Protecteur universel contre les infections pour injecteurs sans aiguille
|
ATE391726T1
(de)
|
1999-10-22 |
2008-04-15 |
Sanofi Pasteur Ltd |
Modifiziertes gp100 und dessen verwendung
|
DE60040383D1
(de)
*
|
1999-10-29 |
2008-11-13 |
Anges Mg Inc |
Gentherapie für diabetische ischämie
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
US20040234539A1
(en)
*
|
1999-11-03 |
2004-11-25 |
Powderject Research Limited |
Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
|
FR2800619B1
(fr)
*
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
Seringue sans aiguille avec un moyen de poussee temporairement retenu
|
US20040109874A1
(en)
*
|
1999-11-10 |
2004-06-10 |
Powderject Vaccines, Inc. |
Induction of mucosal immunity by vaccination via the skin route
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
US7029457B2
(en)
|
1999-11-23 |
2006-04-18 |
Felton International, Inc. |
Jet injector with hand piece
|
FR2802102B1
(fr)
|
1999-12-08 |
2002-07-12 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un tube d'ejection a section constante
|
FR2802103B1
(fr)
|
1999-12-08 |
2003-10-03 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec entrainement du principe actif par effet tube a choc
|
FR2802820B1
(fr)
*
|
1999-12-27 |
2002-10-18 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par effet tube a choc, avec maintien prealable du principe actif sur le cote
|
FR2804329B1
(fr)
|
2000-02-02 |
2002-12-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un opercule contenant le principe actif
|
US6689092B2
(en)
|
2000-03-03 |
2004-02-10 |
Boehringer International Gmbh |
Needle-less injector of miniature type
|
GB0006263D0
(en)
*
|
2000-03-15 |
2000-05-03 |
Powderject Res Ltd |
Apparatus and method for adjusting the characteristics of a needleless syringe
|
US6716190B1
(en)
|
2000-04-19 |
2004-04-06 |
Scimed Life Systems, Inc. |
Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
|
EP1792995A3
(fr)
|
2000-05-08 |
2007-06-13 |
Sanofi Pasteur Limited |
Antigènes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
WO2001085932A2
(fr)
|
2000-05-10 |
2001-11-15 |
Aventis Pasteur Limited |
Polypeptides immunogeniques codes par des minigenes mage et leurs utilisations
|
WO2001089633A2
(fr)
*
|
2000-05-26 |
2001-11-29 |
George Vizirgianakis |
Appareil de traitement et de therapie
|
US20020120228A1
(en)
*
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
US7597692B2
(en)
*
|
2000-06-08 |
2009-10-06 |
Massachusetts Institute Of Technology |
Microscission processes and procedures
|
IL153241A0
(en)
*
|
2000-06-08 |
2003-07-06 |
Powderject Vaccines Inc |
Powder compositions
|
US6706032B2
(en)
*
|
2000-06-08 |
2004-03-16 |
Massachusetts Institute Of Technology |
Localized molecular and ionic transport to and from tissues
|
US20040213798A1
(en)
*
|
2000-06-08 |
2004-10-28 |
Powderject Vaccines, Inc. |
Spray-dried alum compositions
|
GB0018035D0
(en)
|
2000-07-21 |
2000-09-13 |
Powderject Res Ltd |
Needleless syringe
|
WO2002019989A2
(fr)
*
|
2000-09-08 |
2002-03-14 |
Powderject Research Limited |
Formulation de particules d'alginate
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6981660B2
(en)
*
|
2000-09-25 |
2006-01-03 |
Evit Labs |
Shock wave aerosolization apparatus and method
|
US6742721B2
(en)
*
|
2000-09-25 |
2004-06-01 |
Evit Laboratories |
Shock wave aerosolization method and apparatus
|
GB0025147D0
(en)
|
2000-10-13 |
2000-11-29 |
Torsana Diabetes Diagnostics A |
Optical sensor for in situ measurement of analytes
|
DE60139959D1
(de)
|
2000-11-27 |
2009-10-29 |
Powderject Vaccines Inc |
Nukleinsäureadjuvantien
|
CA2430499C
(fr)
*
|
2000-11-30 |
2012-05-22 |
Biovalve Technologies, Inc. |
Systemes d'injection
|
GB0100756D0
(en)
*
|
2001-01-11 |
2001-02-21 |
Powderject Res Ltd |
Needleless syringe
|
US6644309B2
(en)
*
|
2001-01-12 |
2003-11-11 |
Becton, Dickinson And Company |
Medicament respiratory delivery device and method
|
US6722364B2
(en)
*
|
2001-01-12 |
2004-04-20 |
Becton, Dickinson And Company |
Medicament inhalation delivery devices and methods for using the same
|
US6443152B1
(en)
|
2001-01-12 |
2002-09-03 |
Becton Dickinson And Company |
Medicament respiratory delivery device
|
ES2191528B1
(es)
*
|
2001-02-05 |
2004-06-16 |
Danone, S.A. |
Dispositivo para la dosificacion de substancias liquidas.
|
GB0103348D0
(en)
*
|
2001-02-10 |
2001-03-28 |
Medical Res Council |
Delivery of biologically active agents
|
WO2002074406A1
(fr)
|
2001-03-14 |
2002-09-26 |
Penjet Corporation |
Systemes et procedes d'extraction de gaz dissous dans des liquides
|
US20040185055A1
(en)
|
2001-03-19 |
2004-09-23 |
Glenn Gregory M |
Transcutaneous immunostimulation
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
US6755220B2
(en)
|
2001-04-27 |
2004-06-29 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
DE10121255A1
(de)
*
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
|
CA2449593A1
(fr)
*
|
2001-06-08 |
2002-12-19 |
Powderject Vaccines, Inc. |
Compositions lyophilisees de pulverisation
|
US6648850B2
(en)
*
|
2001-06-08 |
2003-11-18 |
Bioject, Inc. |
Durable needle-less jet injector apparatus and method
|
US8061006B2
(en)
*
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
GB0118266D0
(en)
|
2001-07-26 |
2001-09-19 |
Powderject Res Ltd |
Silencing device and method for needleless syringe
|
US20030019558A1
(en)
*
|
2001-07-26 |
2003-01-30 |
Smith Edward R. |
Particle cassette, method and kit therefor
|
NZ531173A
(en)
*
|
2001-07-26 |
2005-06-24 |
Powderject Res Ltd |
Particle cassette, method and kit therefor
|
DE10163326A1
(de)
*
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
DE10163328B4
(de)
*
|
2001-07-30 |
2005-08-11 |
Tecpharma Licensing Ag |
Verabreichungsgerät mit Verdrehsicherung
|
DE10163327A1
(de)
*
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Reservoirmodul mit Kolbenstange
|
DE10163325B4
(de)
*
|
2001-07-30 |
2005-07-28 |
Tecpharma Licensing Ag |
Verriegelungssperre für eine Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts
|
DE20112501U1
(de)
*
|
2001-07-30 |
2002-12-19 |
Disetronic Licensing Ag, Burgdorf |
Verriegelungssperre für eine Verbindung von Gehäuseteilen eines Injektions- oder Infusionsgeräts
|
US20050191361A1
(en)
*
|
2001-08-03 |
2005-09-01 |
Powederject Research Ltd. |
Hydrogel particle formation
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
CN1607941A
(zh)
*
|
2001-11-19 |
2005-04-20 |
贝克顿迪肯森公司 |
粒状药物组合物
|
JP2005513428A
(ja)
|
2001-12-17 |
2005-05-12 |
パウダージェクト リサーチ リミテッド |
非侵襲的または最小侵襲的モニタリング方法
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
EP1458360B1
(fr)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Administration pulmonaire d'aminoglycosides
|
DE20209051U1
(de)
|
2001-12-21 |
2003-04-24 |
Disetronic Licensing Ag, Burgdorf |
Injektionsgerät mit endpositionsblockiertem Dosiseinstellglied
|
US20030130614A1
(en)
*
|
2002-01-09 |
2003-07-10 |
Johnson Lanny L. |
Device for delivering liquid medications or nutrients and gases to local tissue
|
ATE402724T1
(de)
|
2002-02-18 |
2008-08-15 |
Danfoss As |
Vorrichtung zur verabreichung eines medikaments in flüssiger form
|
US20030163111A1
(en)
*
|
2002-02-26 |
2003-08-28 |
Daellenbach Keith K. |
End effector for needle-free injection system
|
CA2380671A1
(fr)
*
|
2002-04-05 |
2003-10-05 |
Stephane Dufresne |
Seringue sans aiguille pour l'injection sous-cutanee de gouttelettes medicamenteuses
|
EP1356820A1
(fr)
|
2002-04-26 |
2003-10-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Vaccin ADN combiné avec un inducteur de l'apoptose de cellules tumorales
|
US7334580B2
(en)
*
|
2002-05-07 |
2008-02-26 |
Smaldone Gerald C |
Methods, devices and formulations for targeted endobronchial therapy
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
US7156823B2
(en)
*
|
2002-06-04 |
2007-01-02 |
Bioject Inc. |
High workload needle-free injection system
|
GB0212885D0
(en)
|
2002-06-05 |
2002-07-17 |
Isis Innovation |
Therapeutic epitopes and uses thereof
|
KR101152561B1
(ko)
|
2002-09-27 |
2012-06-01 |
파우더젝트 리서치 리미티드 |
핵산 코팅된 입자
|
AU2003282683A1
(en)
*
|
2002-10-04 |
2004-05-04 |
Photokinetix Inc. |
Photokinetic delivery of biologically active substances using pulsed incoherent light
|
EP1444999B1
(fr)
*
|
2003-02-03 |
2010-07-21 |
BioWare Technology Co., Ltd |
Pistolet de gène accéléré par gaz de basse pression
|
DE10306716A1
(de)
*
|
2003-02-17 |
2004-09-02 |
Lell, Peter, Dr.-Ing. |
Vorrichtung zum Injizieren eines staub-oder pulverförmigen Stoffs in ein Gewebe eines Körpers
|
WO2004086938A2
(fr)
*
|
2003-03-25 |
2004-10-14 |
Herndon Terry O |
Dispositif de perforation et procede servant a creer des conduits microscopiques
|
DE10316237A1
(de)
*
|
2003-04-09 |
2004-11-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Kanüle und Verfahren zur Einführung einer Kanüle in biologisches Material
|
KR20060019518A
(ko)
*
|
2003-04-21 |
2006-03-03 |
스트라타젠트 라이프 사이언시즈 |
반복적 마이크로제트 약물 전달 장치 및 방법
|
US20060184101A1
(en)
*
|
2003-04-21 |
2006-08-17 |
Ravi Srinivasan |
Microjet devices and methods for drug delivery
|
WO2004110533A1
(fr)
*
|
2003-05-09 |
2004-12-23 |
Anges Mg, Inc. |
Seringue sans aiguille contenant un agent therapeutique
|
JP4956185B2
(ja)
|
2003-06-13 |
2012-06-20 |
スケンディ ファイナンス リミテッド |
避妊及びホルモン補充療法用の調合製剤
|
US7131961B2
(en)
*
|
2003-10-01 |
2006-11-07 |
Bioject, Inc. |
Needle-free injection system
|
KR101225395B1
(ko)
*
|
2003-10-10 |
2013-01-28 |
파우더젝트 백신, 인코포레이티드 |
핵산 구조물
|
US7442182B2
(en)
*
|
2003-10-24 |
2008-10-28 |
Bioject, Inc. |
Spring powered needle-free injection system
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
US20050209553A1
(en)
*
|
2004-03-19 |
2005-09-22 |
Sergio Landau |
Needle-free single-use cartridge and injection system
|
US20050209554A1
(en)
*
|
2004-03-19 |
2005-09-22 |
Sergio Landau |
Needle-free single-use cartridge and injection system
|
JP4210231B2
(ja)
*
|
2004-03-25 |
2009-01-14 |
株式会社資生堂 |
皮膚のシワを改善する美容方法及びシワ改善具
|
EP2409707B8
(fr)
*
|
2004-04-15 |
2015-05-06 |
Alkermes Pharma Ireland Limited |
Dispositif à libération prolongée à base de polymères
|
US20060110423A1
(en)
*
|
2004-04-15 |
2006-05-25 |
Wright Steven G |
Polymer-based sustained release device
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US10105437B2
(en)
|
2004-04-28 |
2018-10-23 |
Btg International Limited |
Epitopes related to coeliac disease
|
CA2564521C
(fr)
|
2004-04-28 |
2017-04-11 |
Btg International Limited |
Epitopes associes a une maladie coeliaque
|
US7884085B2
(en)
|
2004-05-12 |
2011-02-08 |
Baxter International Inc. |
Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
|
DK1765294T3
(da)
|
2004-05-12 |
2008-11-10 |
Baxter Int |
Nukleinsyremikrokugler samt deres fremstilling og afgivelse
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
US20060038044A1
(en)
*
|
2004-08-23 |
2006-02-23 |
Van Steenkiste Thomas H |
Replaceable throat insert for a kinetic spray nozzle
|
US20060089594A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device
|
US20060089593A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device for individual users
|
EP2532378B1
(fr)
|
2004-12-01 |
2016-04-27 |
AcuShot, Inc. |
Injecteur sans aiguille
|
US20070004040A1
(en)
*
|
2005-01-06 |
2007-01-04 |
Brashears Sarah J |
RNAi agents for maintenance of stem cells
|
GB0507997D0
(en)
*
|
2005-02-01 |
2005-05-25 |
Powderject Vaccines Inc |
Nucleic acid constructs
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP2500031A3
(fr)
|
2005-02-24 |
2012-12-26 |
Joslin Diabetes Center, Inc. |
Compositions et procédés de traitement de la perméabilité vasculaire
|
DE102005015801A1
(de)
|
2005-04-06 |
2006-10-19 |
Schreiner Group Gmbh & Co. Kg |
Folienbasierter Schutzmechanismus
|
US20070118093A1
(en)
*
|
2005-06-20 |
2007-05-24 |
Von Muhlen Marcio G |
High-speed jet devices for drug delivery
|
US20070055200A1
(en)
*
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Needle-free jet injection drug delivery device
|
WO2007028167A2
(fr)
|
2005-09-02 |
2007-03-08 |
Iomai Corporation |
Dispositifs d’administration transcutanée de vaccins et d'administration transdermique de médicaments et utilisations idoines
|
US8142391B2
(en)
*
|
2005-11-29 |
2012-03-27 |
Mitchell Stuart B |
Electrostatic transcutaneous hypodermic spray (electrostatic hypospray)
|
JP4402648B2
(ja)
*
|
2005-12-16 |
2010-01-20 |
オリンパス株式会社 |
被検体内導入装置
|
US20080161755A1
(en)
*
|
2006-01-27 |
2008-07-03 |
Bioject Inc. |
Needle-free injection device and priming system
|
CN101374562B
(zh)
|
2006-01-31 |
2011-09-14 |
诺沃-诺迪斯克有限公司 |
用于预填充的医疗射流注射装置的密封件
|
GB0611443D0
(en)
*
|
2006-06-09 |
2006-07-19 |
Powderject Res Ltd |
Improvements in, or relating to, particle cassettes
|
WO2008021133A2
(fr)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
systèmes d'administration osmotiques et ensembles pistons
|
CN100446823C
(zh)
*
|
2006-09-19 |
2008-12-31 |
宁波新芝生物科技股份有限公司 |
一种无创介入治疗系统
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
US9017697B2
(en)
|
2006-10-12 |
2015-04-28 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
FR2908753B1
(fr)
*
|
2006-11-16 |
2011-11-11 |
Becton Dickinson France |
Dispositif pour delivrer automatiquement des doses successives de produit
|
DE102007004855B4
(de)
*
|
2007-01-31 |
2014-03-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat
|
JP2008199905A
(ja)
*
|
2007-02-16 |
2008-09-04 |
Snow Brand Milk Prod Co Ltd |
乳酸菌生残性向上剤
|
WO2008103997A2
(fr)
*
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Dispositifs d'injection sans aiguille et systèmes d'administration de médicament pour ceux-ci
|
EP2157967B1
(fr)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Formulations en suspension de peptides insulinotropes et leurs utilisations
|
GB0708758D0
(en)
|
2007-05-04 |
2007-06-13 |
Powderject Res Ltd |
Particle cassettes and process thereof
|
CA2684946C
(fr)
|
2007-05-16 |
2015-03-31 |
The Brigham And Women's Hospital, Inc. |
Traitement de synucleinopathies
|
GB2449312B
(en)
|
2007-05-18 |
2012-03-14 |
Malvern Instr Ltd |
Method and apparatus for dispersing a sample of particulate material
|
JP4780034B2
(ja)
*
|
2007-05-18 |
2011-09-28 |
株式会社島津製作所 |
針無注射器
|
WO2009058564A2
(fr)
|
2007-11-01 |
2009-05-07 |
Maxygen, Inc. |
Polypeptide immunosuppresseur et acides nucléiques
|
EP2240155B1
(fr)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Dispositifs, formulations et méthodes d administration de plusieurs agents bénéfiques
|
US8021873B2
(en)
|
2008-07-16 |
2011-09-20 |
Boston Microfluidics |
Portable, point-of-care, user-initiated fluidic assay methods and systems
|
US20110117673A1
(en)
*
|
2008-07-16 |
2011-05-19 |
Johnson Brandon T |
Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow
|
EP2385371B1
(fr)
|
2008-09-22 |
2014-10-22 |
Oregon Health and Science University |
Méthodes permettant de détecter une infection par le bacille de Koch
|
DE102008048981A1
(de)
*
|
2008-09-25 |
2010-04-15 |
Lts Lohmann Therapie-Systeme Ag |
Injektor und Zwei-Kammer-System mit sterilen Komponenten
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
US8731841B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9050070B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9060934B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8731840B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072688B2
(en)
*
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8762067B2
(en)
*
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8551505B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8725420B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US20100111857A1
(en)
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8788211B2
(en)
*
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US9060926B2
(en)
*
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US20100111834A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545855B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8232093B2
(en)
|
2009-02-05 |
2012-07-31 |
Indian Institute Of Science |
Apparatus and method for genetically transforming cells
|
EP2405961A4
(fr)
*
|
2009-03-09 |
2012-08-08 |
Purdue Research Foundation |
Dispositif compact pour mélanger et distribuer rapidement des substances à un patient
|
WO2010105096A2
(fr)
|
2009-03-11 |
2010-09-16 |
University Of Massachusetts |
Modulation de la réplication du cytomégalovirus humain par micro-arn 132 (mir132), micro-arn 145 (mir145) et micro-arn 212 (mir212)
|
CN102439150A
(zh)
|
2009-03-27 |
2012-05-02 |
法国国家健康医学研究院 |
用于癌症治疗的卡那霉素反义核酸
|
EP2756845B1
(fr)
|
2009-04-03 |
2017-03-15 |
Dicerna Pharmaceuticals, Inc. |
Procédés et compositions pour l'inhibition spécifique de KRAS par de l'ARN double brin asymétrique
|
GB0906215D0
(en)
|
2009-04-09 |
2009-05-20 |
Lalvani Ajit |
Diagnostic test
|
TWI439302B
(zh)
|
2009-07-14 |
2014-06-01 |
Chien Lung Chen |
傳輸裝置
|
CN101987218B
(zh)
*
|
2009-07-30 |
2013-07-10 |
陈建龙 |
传输装置
|
CN104323981B
(zh)
|
2009-09-28 |
2019-03-12 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
US20120208750A1
(en)
|
2009-09-29 |
2012-08-16 |
Joslin Diabetes Center, Inc. |
Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
|
EP2501433A1
(fr)
*
|
2009-11-20 |
2012-09-26 |
Talima Therapeutics, Inc. |
Dispositifs d'implantation de compositions et procédés et nécessaires à cet effet
|
US8961989B2
(en)
|
2009-11-20 |
2015-02-24 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
CN201888971U
(zh)
*
|
2010-01-08 |
2011-07-06 |
江苏华兰米特医疗科技有限公司 |
无针注射器
|
WO2011098518A2
(fr)
|
2010-02-11 |
2011-08-18 |
Ablynx Nv |
Administration de domaines variables d'immunoglobuline et de produits de construction de ceux-ci
|
CN101797411B
(zh)
*
|
2010-03-18 |
2011-12-07 |
傅雅芬 |
一种气压式无针注射器动力头
|
WO2011123762A1
(fr)
*
|
2010-04-01 |
2011-10-06 |
Glucago Llc |
Procédé et dispositif pour mélanger des substances
|
CA2798837A1
(fr)
|
2010-06-07 |
2011-12-15 |
Pfizer Inc. |
Peptides her-2 et vaccins
|
US8821434B2
(en)
*
|
2010-10-07 |
2014-09-02 |
Massachusetts Institute Of Technology |
Delivery of a solid body and/or a fluid using a linear Lorentz-force actuated needle-free jet injection system
|
US9211378B2
(en)
|
2010-10-22 |
2015-12-15 |
Cequr Sa |
Methods and systems for dosing a medicament
|
AU2011325857A1
(en)
|
2010-11-01 |
2013-05-02 |
University Of Technology, Sydney |
Immune-modulating agents and uses therefor
|
GB201021881D0
(en)
*
|
2010-12-23 |
2011-02-02 |
Profibrix Bv |
Powder delivery device
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US8486002B2
(en)
|
2011-04-19 |
2013-07-16 |
Palo Alto Research Center Incorporated |
Drug delivery devices and methods with collimated gas stream and release-activatable tape
|
US8388569B2
(en)
|
2011-04-19 |
2013-03-05 |
Xerox Corporation |
Delivery devices and methods with collimated gas stream and particle source
|
US8430839B2
(en)
|
2011-04-19 |
2013-04-30 |
Palo Alto Research Center Incorporated |
Drug delivery devices and methods with collimated gas stream and drug reservoir
|
WO2013037804A1
(fr)
|
2011-09-12 |
2013-03-21 |
Laboratorios Del Dr. Esteve, S.A. |
Procédé de surveillance des réponses des lymphocytes t cytotoxiques (ctl) par une réaction d'hypersensibilité de type retardée à l'aide d'épitopes viraux de ctl définis
|
WO2013075132A1
(fr)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Compositions de commutateurs arn thérapeutiques et procédés d'utilisation
|
US20140058319A1
(en)
*
|
2012-03-20 |
2014-02-27 |
Glucago Llc |
Compact Device For Rapidly Mixing and Delivering Substances To a Patient
|
US8992469B2
(en)
|
2012-06-26 |
2015-03-31 |
Glucago Llc |
Reconstitution device
|
US9125995B2
(en)
|
2012-12-05 |
2015-09-08 |
Glucago Llc |
Reconstitution devices
|
US9345487B2
(en)
|
2013-02-05 |
2016-05-24 |
Path Scientific, Llc |
Precision bone drill and method of use
|
EP2769732A1
(fr)
|
2013-02-22 |
2014-08-27 |
Sanofi |
Serpines Procédés de régénération thérapeutique et de fonction des cellules beta
|
EP2851086A1
(fr)
|
2013-09-20 |
2015-03-25 |
Sanofi |
Serpines Procédés de régénération thérapeutique et de fonction des cellules beta
|
WO2014128257A1
(fr)
|
2013-02-22 |
2014-08-28 |
Sanofi |
Serpines : procédés de régénération de cellules bêta thérapeutique et fonction
|
BR112015022025A8
(pt)
|
2013-03-14 |
2019-12-10 |
Hallux Inc |
composição e uso de um agente ativo
|
US9808579B2
(en)
*
|
2013-05-08 |
2017-11-07 |
Elwha Llc |
Needleless injector systems, and related methods and components
|
WO2014183216A1
(fr)
*
|
2013-05-17 |
2014-11-20 |
Socpra Sciences Et Génie S.E.C. |
Seringue sans aiguille et procédé d'administration de particules thérapeutiques
|
CN106975128B
(zh)
*
|
2014-02-26 |
2021-02-26 |
普乐药业有限公司 |
用于递送颗粒的装置
|
WO2015171964A1
(fr)
*
|
2014-05-07 |
2015-11-12 |
Sri International |
Dispositif d'injection sans aiguille
|
US9737251B2
(en)
|
2014-05-28 |
2017-08-22 |
Verily Life Sciences Llc |
Needle-free blood draw
|
EP2959931A1
(fr)
*
|
2014-06-24 |
2015-12-30 |
LTS LOHMANN Therapie-Systeme AG |
Dispositif d'injection sans aiguille
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP3011988A1
(fr)
*
|
2014-10-22 |
2016-04-27 |
LTS LOHMANN Therapie-Systeme AG |
Dispositif d'injection sans aiguille doté d'un gel et d'une membrane
|
US10420826B2
(en)
|
2014-11-11 |
2019-09-24 |
Massachusetts Eye & Ear Infirmary |
Conjunctivitis vaccines
|
JP7105065B2
(ja)
|
2014-12-15 |
2022-07-22 |
ダイセルナ ファーマシューティカルズ, インコーポレイテッド |
リガンド修飾二本鎖核酸
|
US10078207B2
(en)
|
2015-03-18 |
2018-09-18 |
Endochoice, Inc. |
Systems and methods for image magnification using relative movement between an image sensor and a lens assembly
|
SI3277815T1
(sl)
|
2015-04-03 |
2022-01-31 |
University Of Massachusetts |
Ologonukleotidne spojine za zdravljenje preeklampsije in drugih angiogeneznih motenj
|
SI3277814T1
(sl)
|
2015-04-03 |
2020-12-31 |
University Of Massachusetts |
Oligonukleotidne spojine za ciljanja MRNA huntingtina
|
AU2016256895B2
(en)
|
2015-05-07 |
2022-05-26 |
Takeda Pharmaceutical Company Limited |
Glucocerebrosidase gene therapy for parkinson's disease
|
WO2016196851A2
(fr)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Systèmes de mise en place et de retrait d'implant
|
US20160361240A1
(en)
*
|
2015-06-11 |
2016-12-15 |
The Procter & Gamble Company |
Apparatus and methods for modifying keratinous surfaces
|
US10633653B2
(en)
|
2015-08-14 |
2020-04-28 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
EP4435105A2
(fr)
|
2015-09-29 |
2024-09-25 |
Amgen Inc. |
Inhibiteurs de l'asgr pour réduire les taux de cholestérol
|
AU2016355178B9
(en)
|
2015-11-19 |
2019-05-30 |
Massachusetts Institute Of Technology |
Lymphocyte antigen CD5-like (CD5L)-interleukin 12B (p40) heterodimers in immunity
|
KR20180099748A
(ko)
*
|
2015-12-28 |
2018-09-05 |
이노비오 파마수티컬즈, 인크. |
진피내 제트 주입 전기천공 디바이스
|
EP3408391A4
(fr)
|
2016-01-31 |
2019-08-28 |
University of Massachusetts |
Oligonucléotides ramifiés
|
MX2018014016A
(es)
|
2016-05-16 |
2019-08-01 |
Intarcia Therapeutics Inc |
Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
CA3033368A1
(fr)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Oligonucleotides conjugues
|
US10443055B2
(en)
|
2016-12-22 |
2019-10-15 |
Beth Israel Deaconess Medical Center |
Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
JP7406793B2
(ja)
|
2017-06-23 |
2023-12-28 |
ユニバーシティー オブ マサチューセッツ |
2テイル自己デリバリー型siRNAおよび関連方法
|
US20210128702A1
(en)
|
2017-08-11 |
2021-05-06 |
Dana-Farber Cancer Institute, Inc. |
Use of a botulinum toxin agent for treating plasma cell disorders
|
US11821003B2
(en)
|
2017-08-14 |
2023-11-21 |
Sanford Burnham Prebys Medical Discovery Institute |
Cardiogenic mesoderm formation regulators
|
WO2019089216A1
(fr)
|
2017-11-01 |
2019-05-09 |
Dana-Farber Cancer Institute, Inc. |
Méthodes de traitement du cancer
|
CN108553748A
(zh)
*
|
2018-05-11 |
2018-09-21 |
江秀秀 |
B超监视下体内多种细胞植入仪
|
EP3790968A1
(fr)
|
2018-05-11 |
2021-03-17 |
Alpha Anomeric SAS |
Conjugués d'oligonucléotides comprenant des nucléosides de glucide 7'-5 '-alpha-anomériques-bicycliques
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
SG11202101288TA
(en)
|
2018-08-10 |
2021-03-30 |
Univ Massachusetts |
Modified oligonucleotides targeting snps
|
CA3110661A1
(fr)
|
2018-08-29 |
2020-03-05 |
University Of Massachusetts |
Inhibition de proteines kinases pour traiter la maladie de friedreich
|
KR102199724B1
(ko)
*
|
2018-10-05 |
2021-01-07 |
주식회사 피테크 |
무바늘 무통 주사 장치
|
EP3893899A2
(fr)
|
2018-12-12 |
2021-10-20 |
Kite Pharma, Inc. |
Récepteurs antigéniques chimériques et récepteurs de lymphocytes t et méthodes d'utilisation
|
EP3966328A4
(fr)
|
2019-05-06 |
2023-10-18 |
University Of Massachusetts |
Oligonucléotides anti-c9orf72 et procédés associés
|
IT201900007060A1
(it)
|
2019-05-21 |
2020-11-21 |
St Superiore Di Sanita |
Cellule tumorali ingegnerizzate e loro usi
|
CN110038212A
(zh)
*
|
2019-05-29 |
2019-07-23 |
徐小棠 |
一种呼吸内科护理给药多用装置
|
CN110180051B
(zh)
*
|
2019-07-13 |
2021-04-02 |
河南省中医院(河南中医药大学第二附属医院) |
产科护理用清洗装置
|
IT201900012540A1
(it)
|
2019-07-22 |
2021-01-22 |
Humanitas Mirasole Spa |
Inibitori di CHI3L1 e loro usi
|
JP2022547790A
(ja)
|
2019-08-09 |
2022-11-16 |
ユニバーシティー オブ マサチューセッツ |
Snpを標的とする化学修飾オリゴヌクレオチド
|
US12037585B2
(en)
|
2019-12-23 |
2024-07-16 |
University Of Massachusetts |
Oligonucleotides for tissue specific gene expression modulation
|
GB202105455D0
(en)
|
2021-04-16 |
2021-06-02 |
Ucl Business Ltd |
Composition
|
BR112023026862A2
(pt)
|
2021-06-23 |
2024-03-05 |
Beth Israel Deaconess Medical Ct Inc |
Compostos de oligonucleotídeos anti-flt1 otimizados para tratamento de pré-eclâmpsia e outros distúrbios angiogênicos
|
CN118139663A
(zh)
*
|
2021-06-24 |
2024-06-04 |
阿维塔斯有限公司 |
喷雾喷嘴
|
GB202112471D0
(en)
|
2021-09-01 |
2021-10-13 |
King S College London |
Microna systems
|
WO2024052732A1
(fr)
*
|
2022-09-07 |
2024-03-14 |
Particle Vaccine Canada Ltd. |
Procédé et appareil d'administration épidermique de médicaments en poudre
|